Form D · Pharmaceuticals
Zosano Pharma Inc
Fremont, CA · CIK 0001418028
Offering snapshot reported Sep 23, 2011 · SEC filing
- Reported sold
- $4.71M Offering amount: $4.71M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $1 Reported outside-investor minimum
- First sale
- Apr 29, 2011 As reported in this filing
Fundraising history
Reported soldDates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.
What changed?
Latest filing versus its linked predecessor, where available.
- Reported sold$4,092,810 → $4,705,630
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Sep 23, 2011 | Amendment | $4,705,630 | $612,820vs Jun 6, 2011 | 1 | SEC filing |
| Jun 6, 2011 | Initial | $4,092,810 | No comparison | 1 | SEC filing |
| Aug 18, 2010 | Initial | $3,111,261 | No comparison | 3 | SEC filing |
| Mar 30, 2010 | Initial | $39,009,000 | No comparison | 6 | SEC filing |
| Nov 7, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Debt, Option to acquire, Security to be acquired
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-160808
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| N/A | None |
Source: Form D, filed Sep 23, 2011. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| M. James Barnett, Ph.D. | Director |
| M. James Barrett, Ph.D. | Director |
| John P. Brown, Ph.D. | Director |
| Peter Daddona, Ph.D. | Executive |
| Kim Gaumer | Executive |
| Daniel Hunt | Executive |
| Vikram Lamba | Executive |
| David M. Mott | Director |
| John P. Richard | Director |
| Michael Schlamp, Ph.D. | Executive |
| Gail Schulze | Director, Executive |
| Jee Y. Shin | Director |
| Thorsten Von Stein, M.D., Ph.D. | Executive |
| John M. Vuko | Executive |
| Greg Yedinak | Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
34790 Ardentech Court
Fremont, CA, 94555
Fremont, CA, 94555